药房纳洛酮配药趋势:美国2012-2018年
BACKGROUND: The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine milligram equivalents per …
要点
- 2018年每69张高剂量阿片处方仅配1张纳洛酮。
- Medicare支付者自付费用比例高于医疗补助和商业保险。
核心结论
- 尽管纳洛酮配药量大幅增加,但每张高剂量阿片处方的纳洛酮配药率仍低,且全国分布差异显著。
研究设计与样本
- 分析2012-2018年IQVIA零售药房数据,按美国人口普查区域、城乡状态、处方者专业和接受者特征评估纳洛酮配药。
主要发现
- 纳洛酮处方量从2012到2018年大幅增加,仅2017至2018年就增长106%。
- 2018年全国每69张高剂量阿片处方配1张纳洛酮处方。
- 处方者专业间纳洛酮配药差异大。
- 相比医疗补助和商业保险,更高比例医疗保险支付的纳洛酮处方需要自付费用。
关键数值与推荐
- CDC指南推荐当存在过量风险因素时考虑开具纳洛酮,如过量史或物质使用障碍、阿片剂量≥50吗啡毫克当量/天、同时使用苯二氮䓬类药物。
临床怎么用
- 卫生保健提供者可在存在过量风险因素时开具或分发纳洛酮,并指导患者如何使用。
- 改善纳洛酮可及性和分发应与改善阿片处方、实施减害策略、促进阿片使用障碍治疗联系及加强公共卫生与公共安全合作相结合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine milligram equivalents per day [high-dose], and concurrent use of benzodiazepines). In light of the high numbers of drug overdose deaths involving opioids, 36% of which in 2017 involved prescription opioids, improving access to naloxone is a public health priority. CDC examined trends and characteristics of naloxone dispensing from retail pharmacies at the national and county levels in the United States. METHODS: CDC analyzed 2012-2018 retail pharmacy data from IQVIA, a health care, data science, and technology company, to assess U.S. naloxone dispensing by U.S. Census region, urban/rural status, prescriber specialty, and recipient characteristics, including age group, sex, out-of-pocket costs, and method of payment. Factors associated with naloxone dispensing at the county level also were examined. RESULTS: The number of naloxone prescriptions dispensed from retail pharmacies increased substantially from 2012 to 2018, including a 106% increase from 2017 to 2018 alone. Nationally, in 2018, one naloxone prescription was dispensed for every 69 high-dose opioid prescriptions. Substantial regional variation in naloxone dispensing was found, including a twenty-fivefold variation across counties, with lowest rates in the most rural counties. A wide variation was also noted by prescriber specialty. Compared with naloxone prescriptions paid for with Medicaid and commercial insurance, a larger percentage of prescriptions paid for with Medicare required out-of-pocket costs. CONCLUSION: Despite substantial increases in naloxone dispensing, the rate of naloxone prescriptions dispensed per high-dose opioid prescription remains low, and overall naloxone dispensing varies substantially across the country. Naloxone distribution is an important component of the public health response to the opioid overdose epidemic. Health care providers can prescribe or dispense naloxone when overdose risk factors are present and counsel patients on how to use it. Efforts to improve naloxone access and distribution work most effectively with efforts to improve opioid prescribing, implement other harm-reduction strategies, promote linkage to medications for opioid use disorder treatment, and enhance public health and public safety partnerships.
引用
- Guy GP, Haegerich TM, Evans ME, et al. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31393863. doi:10.15585/mmwr.mm6831e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。